Skip to content
Ishita Drugs & Industries logo

Ishita Drugs & Industries

524400 BSE
₹74.40 down 0.20 (0.27%)
Market Cap
₹22.22 Cr
P/E
31.26

Ishita Drugs & Industries (ISHITADR) share price was ₹74.60 at the 28 Oct 2026 close; market capitalisation ₹22.28 Cr; P/E (TTM) 31.34; sector Healthcare. The share price rose 2.2% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue was ₹3.15 Cr, against ₹5.40 Cr a year earlier and net profit was ₹0.23 Cr, against ₹0.30 Cr a year earlier (compared with Jun 2025). Promoters held 50.04% of Ishita Drugs & Industries in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 53/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹74.60 +2.50 +3.47% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹22.22 Cr
P/E (TTM)
31.26
EBITDA
₹1.20 Cr
Return on Equity
6.73%
Debt to Equity
0.01
Book Value
₹38.69
EPS (TTM)
₹2.38
52W High
₹90.85
52W Low
₹66.00

Price-based figures as of 29 Oct 2026, 10:04 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,763.6034.994,23,147 Cr5.060.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,678.5087.842,56,934 Cr15.330.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,588.3072.031,74,524 Cr9.500.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,195.10108.451,18,604 Cr22.380.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,183.2026.331,18,025 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,338.8034.671,11,747 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,365.2032.711,10,289 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Ishita Drugs & Industries (this company)
₹74.4031.2622 Cr1.920.00%6.73%9.81%13 Cr1 Cr
Median 8 companies₹1,564.4034.831,18,314 Cr4.710.47%12.98%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

53 Average
Overall score

Data confidence 98/100

Category scores

Quality Strong 75
Returns, margins, earnings quality 22% weight
Valuation Weak 41
Cheap vs sector & own history 24% weight
Growth Poor 10
Sales & profit trajectory 9% weight
Financial Health Strong 85
Solvency, leverage, coverage 9% weight
Momentum Average 49
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

2
  • Company has reduced debt.
  • Company is almost debt free.

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 1.00% over past five years.
  • Company has a low return on equity of 7.72% over last 3 years.
  • Earnings include an other income of Rs.0.43 Cr.

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
7
Bullish
0

Overall

Bullish

Bearish
5
Neutral
7
Bullish
7

Moving Averages

Bullish

Bearish
3
Neutral
0
Bullish
7

Growth Rate

Revenue Growth
-1.31% lower than 3Y

change over 1 year

Net Income Growth
-11.11% lower than 3Y

change over 1 year

Cash Flow Change
208%

change over 1 year

EBITDA Margin Change
-6.08%

change over 1 year Operating margin 9.84% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
3.09
4.4
3.21
4.5
3.03
3.27
4.13
4.56
5.4
3.07
3.14
3.06
3.15
Expenses
2.91
4.18
2.99
4.2
2.86
3.03
3.83
4.27
5.06
2.89
3
2.96
2.84
Operating Profit
0.18
0.22
0.22
0.3
0.17
0.24
0.3
0.29
0.34
0.18
0.14
0.1
0.31
OPM %
5.83%
5%
6.85%
6.67%
5.61%
7.34%
7.26%
6.36%
6.3%
5.86%
4.46%
3.27%
9.84%
Other Income
0.07
0.1
0.01
0.1
0.06
0.05
0.07
0.16
0.09
0.07
0.1
0.22
0.04
Interest
0.03
0.01
0.04
0.02
0.01
0
0.02
0.04
0.02
0
0.02
0.02
0
Depreciation
0.03
0.03
0.03
0.01
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.02
0.05
PBT
0.19
0.28
0.16
0.37
0.19
0.26
0.32
0.38
0.38
0.22
0.19
0.28
0.3
Tax %
26.32%
25%
25%
24.32%
26.32%
23.08%
25%
23.68%
23.68%
36.36%
21.05%
35.71%
23.33%
Net Profit
0.14
0.21
0.12
0.28
0.15
0.19
0.24
0.29
0.3
0.14
0.16
0.18
0.23
EPS (₹)
0.47
0.7
0.4
0.94
0.5
0.64
0.8
0.97
1
0.47
0.54
0.6
0.77
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
7.54
7.1
6.44
6.9
9.09
14.83
13.95
14.09
12.07
15.19
15
14.66
12.42
Expenses
7.23
6.82
6.08
6.45
8.57
14.07
13.03
13.01
11.31
14.28
14.01
13.89
11.69
Operating Profit
0.31
0.28
0.36
0.45
0.52
0.76
0.92
1.08
0.76
0.91
0.99
0.77
0.73
OPM %
4.11%
3.94%
5.59%
6.52%
5.72%
5.12%
6.59%
7.67%
6.3%
5.99%
6.6%
5.25%
5.88%
Other Income
0.17
0.13
0.08
0.12
0.16
0.16
0.31
0.11
0.2
0.28
0.34
0.47
0.43
Interest
0.04
0.06
0.04
0.11
0.06
0.03
0.03
0.02
0.05
0.09
0.07
0.06
0.04
Depreciation
0.15
0.15
0.14
0.14
0.16
0.18
0.15
0.13
0.13
0.11
0.11
0.1
0.13
PBT
0.29
0.2
0.26
0.32
0.46
0.71
1.05
1.04
0.78
0.99
1.15
1.08
0.99
Tax %
24.14%
30%
30.77%
25%
26.09%
23.94%
20.95%
23.08%
25.64%
24.24%
25.22%
27.78%
—
Net Profit
0.22
0.14
0.18
0.25
0.35
0.55
0.83
0.8
0.58
0.75
0.87
0.78
0.71
EPS (₹)
0.74
0.47
0.6
0.84
1.17
1.84
2.78
2.68
1.94
2.51
2.91
2.61
2.38
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2.99
2.99
2.99
2.99
2.99
2.99
2.99
2.99
2.99
2.99
2.99
2.99
Reserves
2.5
2.64
2.82
3.07
3.42
3.97
4.8
5.61
6.18
6.93
7.8
8.58
Borrowings
0.09
1.13
0.01
0.13
0.2
0.29
0.04
0
0.96
0
3.9
0.08
Other Liabilities
1.37
1.43
1.37
0.97
1.73
2.3
1.43
2.66
1.27
0.89
1.6
0.95
Total Liabilities
6.95
8.19
7.19
7.16
8.34
9.55
9.26
11.26
11.4
10.81
16.29
12.6
Fixed Assets
1.26
1.11
1.02
1.19
1.3
1.14
1
0.88
0.89
0.8
0.88
0.88
CWIP
0
0
0
0
0
0
0
0
0
0
0
1.75
Investments
1.82
2.15
2.7
3.15
4.04
5.29
3.11
4.06
3.39
3.34
3.87
4.45
Other Assets
3.87
4.93
3.47
2.82
3
3.12
5.15
6.32
7.12
6.67
11.54
5.52
Total Assets
6.95
8.19
7.19
7.16
8.34
9.55
9.26
11.26
11.4
10.81
16.29
12.6
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.11
0.26
0.52
0.72
0.79
1.05
-0.67
3.08
-2.9
2.12
-3.64
3.92
Investing
-0.34
-0.28
-0.55
-0.69
-1.06
-1.15
2.45
-0.93
0.59
0.13
-0.67
-2.24
Financing
-0.07
1.07
-1.05
0.05
0.09
0.09
-0.24
0
1.05
-0.87
4.33
-3.81
Net Cash Flow
-0.29
1.05
-1.08
0.08
-0.19
-0.01
1.54
2.14
-1.25
1.38
0.02
-2.13
Free Cash Flow
0.06
0.25
0.48
0.41
0.52
1.04
-0.67
3.06
-3.03
2.09
-3.82
2.07
CFO/OP
35
93
144
160
152
138
-73
285
-382
233
-368
509
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
60.51
96.65
96.35
43.38
47.38
32.24
39.77
13.99
54.43
16.82
46.23
25.15
Inventory Days
91.6
55.65
51.49
55.56
42.2
18.49
23.06
34.81
68.22
34.27
149
32.57
Days Payable
78.31
91.07
108
43.21
78.7
60.25
34.76
73.22
36.67
14.87
31.78
19.83
Cash Conversion Cycle
73.8
61.23
39.35
55.72
10.88
-9.52
28.07
-24.41
85.99
36.22
164
37.89
Working Capital Days
64.38
10.28
56.68
32.27
8.03
-10.83
29.83
-27.46
42.94
21.87
30.17
43.82
ROCE %
5.98%
4.21%
4.77%
7.16%
8.12%
10.68%
14.32%
12.9%
8.86%
10.77%
9.91%
8.66%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Ishita Drugs & Industries insights

65 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

Promot.50.04%Others1.63%Public48.33%As ofSep 2026

Documents

Frequently Asked Questions about Ishita Drugs & Industries

What does Ishita Drugs & Industries Ltd do?
Incorporated in 1992, Ishita Drugs & Industries Ltd is engaged in the manufacturing of various APIs and drug intermediates[1]
Where is Ishita Drugs & Industries Ltd (ISHITADR) listed?
Ishita Drugs & Industries Ltd trades under code 524400 on the BSE.
Which sector does Ishita Drugs & Industries Ltd belong to?
Ishita Drugs & Industries Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Ishita Drugs & Industries Ltd?
Ishita Drugs & Industries Ltd has a market capitalisation of ₹22.22 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Ishita Drugs & Industries Ltd?
Ishita Drugs & Industries Ltd trades at a PE ratio of 31.26 as of 29 Oct 2026, on earnings per share of ₹2.38, against a book value of ₹38.69 per share.
What is the 52-week high and low of Ishita Drugs & Industries Ltd?
Over the last 52 weeks Ishita Drugs & Industries Ltd has traded between ₹66 and ₹90.85 as of 29 Oct 2026.
What is the Return on Equity (ROE) of Ishita Drugs & Industries Ltd?
Ishita Drugs & Industries Ltd reported a return on equity of 6.73%. Its debt-to-equity ratio is 0.01.

Company Information

Incorporated in 1992, Ishita Drugs & Industries Ltd is engaged in the manufacturing of various APIs and drug intermediates[1]

Website ishitadrugs.com
Listed 1997-12-05
Face Value ₹ 10
Shares Outstanding 29,86,667

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524400.md for Ishita Drugs & Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month